| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 402.96B | 350.02B | 307.39B | 282.84B | 257.64B |
| Gross Profit | 240.43B | 203.71B | 174.06B | 156.63B | 146.70B |
| EBITDA | 179.96B | 135.39B | 97.97B | 85.16B | 103.52B |
| Net Income | 132.17B | 100.12B | 73.80B | 59.97B | 76.03B |
Balance Sheet | |||||
| Total Assets | 595.28B | 450.26B | 402.39B | 365.26B | 359.27B |
| Cash, Cash Equivalents and Short-Term Investments | 126.84B | 95.66B | 110.92B | 113.76B | 139.65B |
| Total Debt | 72.03B | 25.46B | 27.12B | 29.68B | 28.39B |
| Total Liabilities | 180.02B | 125.17B | 119.01B | 109.12B | 107.63B |
| Stockholders Equity | 415.26B | 325.08B | 283.38B | 256.14B | 251.63B |
Cash Flow | |||||
| Free Cash Flow | 73.27B | 72.76B | 69.50B | 60.01B | 67.01B |
| Operating Cash Flow | 164.71B | 125.30B | 101.75B | 91.50B | 91.65B |
| Investing Cash Flow | -120.29B | -45.54B | -27.06B | -20.30B | -35.52B |
| Financing Cash Flow | -37.39B | -79.73B | -72.09B | -69.76B | -61.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $3.71T | 28.69 | 35.00% | 0.26% | 13.55% | 34.26% | |
81 Outperform | $1.53T | 27.52 | 30.56% | 0.32% | 22.17% | -2.66% | |
80 Outperform | $3.66T | 23.95 | 159.94% | 0.41% | 10.07% | 25.58% | |
74 Outperform | $2.89T | 23.36 | 33.61% | 0.71% | 16.67% | 28.60% | |
63 Neutral | $447.28B | 27.89 | 57.35% | 1.00% | 11.08% | 29.56% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
46 Neutral | $41.35B | 77.69 | 2.02% | ― | -2.70% | -56.75% |